Therapeutic angiogenesis with the use of vascular endothelial growth factor 165 gene in the myocardium of miniature swine

Acta Physiologica Sinica

Volumn 53, Issue 3, 2001, Pages 183-187

  Zhang, Duan Zhen ^a   Gai, Lu Yue ^a   Chen, Yi Wang ^b   Fan, Rui Yun ^a   Wen, Ying Feng ^a   Dong, Wei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Collateral circulation; Endothelial growth factor; Gene therapy; Ischemic heart disease; Myocardial function

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165; VIRUS VECTOR; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CIRCUMFLEX BRANCH; ELECTROCARDIOGRAM; GENE THERAPY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IMAGE ANALYSIS; NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SWINE; TREATMENT OUTCOME; ADENOVIRUS; ANIMAL; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FEMALE; GENE VECTOR; GENETICS; HEART STROKE VOLUME; IN VITRO STUDY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY;

ADENOVIRIDAE; ANIMAL; COLLATERAL CIRCULATION; CORONARY CIRCULATION; ENDOTHELIAL GROWTH FACTORS; ENGLISH ABSTRACT; FEMALE; GENETIC VECTORS; IN VITRO; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MYOCARDIAL REPERFUSION INJURY; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; STROKE VOLUME; SWINE, MINIATURE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 1842690439     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med, 1999, 77:527-543.
2. Mark CA, Budenbender KT, Magovem CJ et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg, 1998, 27:699-709.
3. Mark CA, Patel SR, Schwarz EA et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg, 1998, 115:168-177.
4. Alexander MY, Webster KA, Mcdonald PH et al. Gene transfer and models of gene therapy for the myocardium. Clin Exp Phamacol Physiol, 1999, 26:661-668.
5. Losordo DW, Vale PR, Symes JF et al. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation, 1998, 98:2800-2804.
6. Yang KTA, Chen HD. Evaluation of global and regional left ventricular function using technetium-99m sestamibi ECG-gated single-photon emission tomography. Eur J Nucl Med, 1998, 25:515-521.
7. Tadamura E, Kudoh T, Motooka M et al. Assessment of regional and global left ventricular function by reinjection Tl-201 and rest Tc-99m sestamibi ECG-gated SPECT. J Am Coll Cardiol, 1999, 33(4):991-997.
8. Rentrop KP, Cohen M, Blanke H et al. Change in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol, 1985, 5:587-592.
9. Yamagishi S, Yonekura H, Yamamoto Y et al. Vascular endothelial growth factor acts as a pericyte mitogen under hyporic conditions. Lab Invest, 1999, 79:501-509.
10. Sirois MG, Edelman ER. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol, 1997, 272:H2746-H2756.
11. Magovern CJ, Mark CA, Zhang J et al. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum Gene Ther, 1997, 8(2):215-227.
12. White FC, Carroll SM, Magnet A et al. Coronary collateral development in swine after coronary artery occlusion. Circ Res, 1992, 71:1490-1500.
13. O'Riordan CR, Lachapelle A, Delgado C et al. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gen Ther, 1999, 10:1349-1358.
14. Li J, Brown LF, Hibbert MG et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol, 1996, 270:H1803-H1811.
15. Banai S, Shweiki D, Pinson A et al. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implication for coronary angiogenesis. Cardiovasc Res, 1994, 28:1176-1179.
16. Shinohara K. The expression and the role of vascular endothelial growth factor in human normal and myocardial infarcted heart. Hokkaido Igaku Zasshi, 1994, 69(4):978-993.
17. Inoue M, Itoh H, Ueda M et al. Vascular endothelial growth factor expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circ, 1998, 98:2108-2116.
18. Patel SR, Lee LY, Mark CA et al. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gen Ther, 1999, 10: 1331-1348.
19. Rosengart TK, Leonard YL, Shailen KP et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the vascular endothelial growth factor 121 cDNA. Ann Surg, 1999, 230(4):466-472.